Kodak $765M Federal Loan Process Involved No Wrongdoing, DFC Concludes
There was no wrongdoing involved in the process of Eastman Kodak Company (NYSE: KODK) receiving a $765 million federal loan for its pharmaceuticals foray, the U.S. International Development Finance Corp. has reportedly concluded.
